Study: NCT00698425

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: EyeGate II® Drug Delivery System
Description: Transscleral iontophoresis using citrate buffer delivered by EyeGate II® Drug Delivery System

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: EyeGate II® Drug Delivery System
Description: Transscleral iontophoresis using citrate buffer delivered by EyeGate II® Drug Delivery System

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: EyeGate II® Drug Delivery System
Description: Transscleral iontophoresis using citrate buffer delivered by EyeGate II® Drug Delivery System

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: EyeGate II® Drug Delivery System
Description: Transscleral iontophoresis using citrate buffer delivered by EyeGate II® Drug Delivery System

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: EyeGate II® Drug Delivery System
Description: Transscleral iontophoresis using citrate buffer delivered by EyeGate II® Drug Delivery System

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: EyeGate II® Drug Delivery System
Description: Transscleral iontophoresis using citrate buffer delivered by EyeGate II® Drug Delivery System

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: EyeGate II® Drug Delivery System
Description: Transscleral iontophoresis using citrate buffer delivered by EyeGate II® Drug Delivery System

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: EyeGate II® Drug Delivery System
Description: Transscleral iontophoresis using citrate buffer delivered by EyeGate II® Drug Delivery System

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: EyeGate II® Drug Delivery System
Description: Transscleral iontophoresis using citrate buffer delivered by EyeGate II® Drug Delivery System

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: EyeGate II® Drug Delivery System
Description: Transscleral iontophoresis using citrate buffer delivered by EyeGate II® Drug Delivery System

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: EyeGate II® Drug Delivery System
Description: Transscleral iontophoresis using citrate buffer delivered by EyeGate II® Drug Delivery System

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: EyeGate II® Drug Delivery System
Description: Transscleral iontophoresis using citrate buffer delivered by EyeGate II® Drug Delivery System

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: EyeGate II® Drug Delivery System
Description: Transscleral iontophoresis using citrate buffer delivered by EyeGate II® Drug Delivery System

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: EyeGate II® Drug Delivery System
Description: Transscleral iontophoresis using citrate buffer delivered by EyeGate II® Drug Delivery System

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: EyeGate II® Drug Delivery System
Description: Transscleral iontophoresis using citrate buffer delivered by EyeGate II® Drug Delivery System

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: EyeGate II® Drug Delivery System
Description: Transscleral iontophoresis using citrate buffer delivered by EyeGate II® Drug Delivery System

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: EyeGate II® Drug Delivery System
Description: Transscleral iontophoresis using citrate buffer delivered by EyeGate II® Drug Delivery System

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: EyeGate II® Drug Delivery System
Description: Transscleral iontophoresis using citrate buffer delivered by EyeGate II® Drug Delivery System

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: EyeGate II® Drug Delivery System
Description: Transscleral iontophoresis using citrate buffer delivered by EyeGate II® Drug Delivery System

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Citrate buffer
Description: Transscleral iontophoresis using citrate buffer delivered by EyeGate II® Drug Delivery System

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Citrate buffer
Description: Transscleral iontophoresis using citrate buffer delivered by EyeGate II® Drug Delivery System

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Citrate buffer
Description: Transscleral iontophoresis using citrate buffer delivered by EyeGate II® Drug Delivery System

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Citrate buffer
Description: Transscleral iontophoresis using citrate buffer delivered by EyeGate II® Drug Delivery System

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Citrate buffer
Description: Transscleral iontophoresis using citrate buffer delivered by EyeGate II® Drug Delivery System

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Citrate buffer
Description: Transscleral iontophoresis using citrate buffer delivered by EyeGate II® Drug Delivery System

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Citrate buffer
Description: Transscleral iontophoresis using citrate buffer delivered by EyeGate II® Drug Delivery System

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Citrate buffer
Description: Transscleral iontophoresis using citrate buffer delivered by EyeGate II® Drug Delivery System

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Citrate buffer
Description: Transscleral iontophoresis using citrate buffer delivered by EyeGate II® Drug Delivery System

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Citrate buffer
Description: Transscleral iontophoresis using citrate buffer delivered by EyeGate II® Drug Delivery System

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Citrate buffer
Description: Transscleral iontophoresis using citrate buffer delivered by EyeGate II® Drug Delivery System

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Citrate buffer
Description: Transscleral iontophoresis using citrate buffer delivered by EyeGate II® Drug Delivery System

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Citrate buffer
Description: Transscleral iontophoresis using citrate buffer delivered by EyeGate II® Drug Delivery System

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Citrate buffer
Description: Transscleral iontophoresis using citrate buffer delivered by EyeGate II® Drug Delivery System

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Citrate buffer
Description: Transscleral iontophoresis using citrate buffer delivered by EyeGate II® Drug Delivery System

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Citrate buffer
Description: Transscleral iontophoresis using citrate buffer delivered by EyeGate II® Drug Delivery System

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Citrate buffer
Description: Transscleral iontophoresis using citrate buffer delivered by EyeGate II® Drug Delivery System

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Citrate buffer
Description: Transscleral iontophoresis using citrate buffer delivered by EyeGate II® Drug Delivery System

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Citrate buffer
Description: Transscleral iontophoresis using citrate buffer delivered by EyeGate II® Drug Delivery System